title: Hu-antibody-positive patients with or without cancer have similar clinical profiles.
authors.forename: A
authors.initials: A
authors.lastname: Lladó
authors.forename: A F
authors.initials: AF
authors.lastname: Carpentier
authors.forename: J
authors.initials: J
authors.lastname: Honnorat
authors.forename: P
authors.initials: P
authors.lastname: Sillevis-Smitt
authors.forename: A
authors.initials: A
authors.lastname: Twijnstra
authors.forename: Y
authors.initials: Y
authors.lastname: Blanco
authors.forename: I K
authors.initials: IK
authors.lastname: Hart
authors.forename: A
authors.initials: A
authors.lastname: Saiz
authors.forename: F
authors.initials: F
authors.lastname: Graus
mesh_terms: D000328:Adult; D000368:Aged; D000974:Antibodies, Antinuclear / Q000032:analysis; D000917:Antibody Formation; D016022:Case-Control Studies; D051959:ELAV Proteins / Q000276:immunology*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D009369:Neoplasms / Q000150:complications* / Q000276:immunology*; D020364:Paraneoplastic Polyneuropathy / Q000276:immunology*
chemical_list: D000974:Antibodies, Antinuclear; D051959:ELAV Proteins